Business Context and Reporting Period
Company: Can-Fite Biopharma Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: October 26, 2015
Context: The filing announces the scheduling of a Special General Meeting of Shareholders and a Special General Meeting of Series 10 Warrant Holders. Both meetings are set for November 26, 2015, at the Company's offices in Petach Tikva, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice regarding shareholder meetings and does not contain financial statements or performance data.
Material Changes
No material financial changes or operational updates are disclosed in this filing. The document serves solely to notify investors of upcoming corporate governance events.
Guidance, Outlook, and Corporate Actions
- Upcoming Meetings:
- Special General Meeting of Shareholders: November 26, 2015, at 4:00 p.m. (Israel time).
- Special General Meeting of Series 10 Warrant Holders: November 26, 2015, at 4:30 p.m. (Israel time).
- Attached Documents: The filing incorporates by reference the Notice and Proxy Statement (Exhibit 99.1), Proxy Cards for ordinary shares (Exhibit 99.2), Voting Instruction Cards for ADS holders (Exhibit 99.3), and Proxy Cards for Series 10 Warrant holders (Exhibit 99.4).
- Proposal Details: Specific proposals to be voted upon are described in the attached Notice and Proxy Statement, not in the body of this Form 6-K.
Key Facts for Investor Verification
- Verify the specific proposals to be voted on by reviewing Exhibit 99.1 (Notice and Proxy Statement).
- Confirm the voting procedures and deadlines for both ordinary shareholders and Series 10 Warrant holders.
- Note that this filing does not contain financial results; investors should refer to the most recent Form 20-F or quarterly reports for financial data.